ADAM22 and developmental and epileptic encephalopathy: Recently, biallelic pathogenic variants in ADAM22 were reported in patients with neonatal/infantile-onset developmental and epileptic encephalopathy (DEE).18 The patients show more severe and wider ranges of clinical phenotypes including developmental/intellectual delay and behavioural abnormalities than those with LGI1-related ADEAF.